Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A

Blood Vessels Thrombosis & Hemostasis · Published 2026-07-01 · DOI 10.1016/j.bvth.2026.100195

Free full text

Authors (6)

Ming Y. Lim, Satoko Ito, George Goshua, Nathorn Chaiyakunapruk, Minkyoung Yoo, Richard Nelson

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lim, M., Ito, S., Goshua, G., et al. (2026). Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A. Blood Vessels Thrombosis & Hemostasis. https://doi.org/10.1016/j.bvth.2026.100195

Related articles

• Abnormal whole-blood viscoelastic test results in patients with bleeding disorder of unknown cause · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Doxycycline for Epistaxis in Hereditary Hemorrhagic Telangiectasia: Genotype-Stratified Outcomes · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Sirolimus Outperforms Alpelisib in Models of NRASQ61R-Driven Vascular Overgrowth · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2 · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• NETs contribute to acute episodes but not ADAMTS13 relapses in immune-mediated thrombotic thrombocytopenic purpura · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• VLX-1005, but not argatroban, prevents ITAM-mediated platelet activation and heparin-induced thrombocytopenia · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Successful eltrombopag discontinuation in paraneoplastic immune thrombocytopenia: a case report · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes · Blood Vessels Thrombosis & Hemostasis · 2025 · Same journal
• Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal
• Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells · Blood Vessels Thrombosis & Hemostasis · 2026 · Same journal